AFOG_EMENI
ID AFOG_EMENI Reviewed; 2527 AA.
AC Q5BEJ4; C8VTX6;
DT 08-JUN-2016, integrated into UniProtKB/Swiss-Prot.
DT 26-APR-2005, sequence version 1.
DT 03-AUG-2022, entry version 136.
DE RecName: Full=Asperfuranone polyketide synthase afoG {ECO:0000305};
DE EC=2.3.1.- {ECO:0000305|PubMed:19199437};
DE AltName: Full=Asperfuranone biosynthesis protein B {ECO:0000303|PubMed:19199437};
GN Name=afoG {ECO:0000303|PubMed:19199437}; ORFNames=AN1036;
OS Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 /
OS M139) (Aspergillus nidulans).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC Aspergillus subgen. Nidulantes.
OX NCBI_TaxID=227321;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139;
RX PubMed=16372000; DOI=10.1038/nature04341;
RA Galagan J.E., Calvo S.E., Cuomo C., Ma L.-J., Wortman J.R., Batzoglou S.,
RA Lee S.-I., Bastuerkmen M., Spevak C.C., Clutterbuck J., Kapitonov V.,
RA Jurka J., Scazzocchio C., Farman M.L., Butler J., Purcell S., Harris S.,
RA Braus G.H., Draht O., Busch S., D'Enfert C., Bouchier C., Goldman G.H.,
RA Bell-Pedersen D., Griffiths-Jones S., Doonan J.H., Yu J., Vienken K.,
RA Pain A., Freitag M., Selker E.U., Archer D.B., Penalva M.A., Oakley B.R.,
RA Momany M., Tanaka T., Kumagai T., Asai K., Machida M., Nierman W.C.,
RA Denning D.W., Caddick M.X., Hynes M., Paoletti M., Fischer R., Miller B.L.,
RA Dyer P.S., Sachs M.S., Osmani S.A., Birren B.W.;
RT "Sequencing of Aspergillus nidulans and comparative analysis with A.
RT fumigatus and A. oryzae.";
RL Nature 438:1105-1115(2005).
RN [2]
RP GENOME REANNOTATION.
RC STRAIN=FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139;
RX PubMed=19146970; DOI=10.1016/j.fgb.2008.12.003;
RA Wortman J.R., Gilsenan J.M., Joardar V., Deegan J., Clutterbuck J.,
RA Andersen M.R., Archer D., Bencina M., Braus G., Coutinho P., von Dohren H.,
RA Doonan J., Driessen A.J., Durek P., Espeso E., Fekete E., Flipphi M.,
RA Estrada C.G., Geysens S., Goldman G., de Groot P.W., Hansen K.,
RA Harris S.D., Heinekamp T., Helmstaedt K., Henrissat B., Hofmann G.,
RA Homan T., Horio T., Horiuchi H., James S., Jones M., Karaffa L.,
RA Karanyi Z., Kato M., Keller N., Kelly D.E., Kiel J.A., Kim J.M.,
RA van der Klei I.J., Klis F.M., Kovalchuk A., Krasevec N., Kubicek C.P.,
RA Liu B., Maccabe A., Meyer V., Mirabito P., Miskei M., Mos M., Mullins J.,
RA Nelson D.R., Nielsen J., Oakley B.R., Osmani S.A., Pakula T., Paszewski A.,
RA Paulsen I., Pilsyk S., Pocsi I., Punt P.J., Ram A.F., Ren Q., Robellet X.,
RA Robson G., Seiboth B., van Solingen P., Specht T., Sun J.,
RA Taheri-Talesh N., Takeshita N., Ussery D., vanKuyk P.A., Visser H.,
RA van de Vondervoort P.J., de Vries R.P., Walton J., Xiang X., Xiong Y.,
RA Zeng A.P., Brandt B.W., Cornell M.J., van den Hondel C.A., Visser J.,
RA Oliver S.G., Turner G.;
RT "The 2008 update of the Aspergillus nidulans genome annotation: a community
RT effort.";
RL Fungal Genet. Biol. 46:S2-13(2009).
RN [3]
RP FUNCTION, AND DISRUPTION PHENOTYPE.
RX PubMed=19199437; DOI=10.1021/ja8088185;
RA Chiang Y.M., Szewczyk E., Davidson A.D., Keller N., Oakley B.R., Wang C.C.;
RT "A gene cluster containing two fungal polyketide synthases encodes the
RT biosynthetic pathway for a polyketide, asperfuranone, in Aspergillus
RT nidulans.";
RL J. Am. Chem. Soc. 131:2965-2970(2009).
RN [4]
RP BIOTECHNOLOGY.
RX PubMed=20148857; DOI=10.1111/j.1742-7843.2010.00545.x;
RA Wang C.C., Chiang Y.M., Praseuth M.B., Kuo P.L., Liang H.L., Hsu Y.L.;
RT "Asperfuranone from Aspergillus nidulans inhibits proliferation of human
RT non-small cell lung cancer A549 cells via blocking cell cycle progression
RT and inducing apoptosis.";
RL Basic Clin. Pharmacol. Toxicol. 107:583-589(2010).
CC -!- FUNCTION: Polyketide synthase; part of the gene cluster that mediates
CC the biosynthesis of asperfuranone, a probable antitumor agent
CC (PubMed:19199437). The polyketide synthase afoG is responsible for
CC producing the 3,5-dimethyloctadienone moiety from acetyl-CoA, three
CC malonyl-CoA, and two S-adenosyl methionines (SAM) (PubMed:19199437).
CC The 3,5-dimethyloctadienone moiety is then loaded onto the SAT domain
CC of afoE and extended with four malonyl-CoA and one SAM, which leads to
CC the formation of 2,4-dihydroxy-6-(5,7-dimethyl-2-oxo-trans-3-trans-5-
CC nonadienyl)-3-methylbenzaldehyde (compound 2) after reductive release
CC and aldol condensation (PubMed:19199437). AfoD is the next enzyme in
CC the biosynthesis sequence and hydroxylates the side chain at the
CC benzylic position of compound 2 (PubMed:19199437). After benzylic
CC hydroxylation, a furan ring is formed after five-member ring hemiacetal
CC formation and water elimination (PubMed:19199437). AfoF and afoC are
CC proposed to oxidize the R-diketone proton and to reduce the
CC unconjugated carbonyl group, respectively, to generate asperfuranone
CC (PubMed:19199437). Since no intermediates could be isolated from afoF
CC and afoC deletants, the sequence of these two enzymes is not fully
CC understood (PubMed:19199437). Moreover, since afoC deletant still
CC produces a small amount of asperfuranone, other endogenous
CC oxidoreductases might catalyze the same reaction with much less
CC efficiency (PubMed:19199437). {ECO:0000269|PubMed:19199437}.
CC -!- INDUCTION: Expression is regulated by the asperfuranone cluster
CC transcription factor afoA (PubMed:19199437).
CC {ECO:0000269|PubMed:19199437}.
CC -!- DISRUPTION PHENOTYPE: Completely abolishes the production of
CC asperfuranone (PubMed:19199437). {ECO:0000269|PubMed:19199437}.
CC -!- BIOTECHNOLOGY: Asperfuranone provides anti-proliferative activity in
CC human non-small cell lung cancer cells (PubMed:20148857).
CC {ECO:0000269|PubMed:20148857}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BN001308; CBF88289.1; -; Genomic_DNA.
DR EMBL; AACD01000015; EAA65604.1; -; Genomic_DNA.
DR RefSeq; XP_658640.1; XM_653548.1.
DR AlphaFoldDB; Q5BEJ4; -.
DR SMR; Q5BEJ4; -.
DR STRING; 162425.CADANIAP00001610; -.
DR PRIDE; Q5BEJ4; -.
DR EnsemblFungi; CBF88289; CBF88289; ANIA_01036.
DR EnsemblFungi; EAA65604; EAA65604; AN1036.2.
DR GeneID; 2876812; -.
DR KEGG; ani:AN1036.2; -.
DR VEuPathDB; FungiDB:AN1036; -.
DR eggNOG; KOG1202; Eukaryota.
DR HOGENOM; CLU_000022_31_0_1; -.
DR InParanoid; Q5BEJ4; -.
DR OMA; GPGPHWD; -.
DR OrthoDB; 19161at2759; -.
DR Proteomes; UP000000560; Chromosome VIII.
DR Proteomes; UP000005890; Unassembled WGS sequence.
DR GO; GO:0004312; F:fatty acid synthase activity; IBA:GO_Central.
DR GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR GO; GO:1900554; P:asperfuranone biosynthetic process; IMP:AspGD.
DR GO; GO:0006633; P:fatty acid biosynthetic process; IBA:GO_Central.
DR GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR GO; GO:0019748; P:secondary metabolic process; NAS:AspGD.
DR GO; GO:0044550; P:secondary metabolite biosynthetic process; IBA:GO_Central.
DR Gene3D; 1.10.1200.10; -; 1.
DR Gene3D; 3.10.129.110; -; 1.
DR Gene3D; 3.40.366.10; -; 1.
DR Gene3D; 3.40.47.10; -; 1.
DR Gene3D; 3.40.50.150; -; 1.
DR InterPro; IPR001227; Ac_transferase_dom_sf.
DR InterPro; IPR036736; ACP-like_sf.
DR InterPro; IPR014043; Acyl_transferase.
DR InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR InterPro; IPR011032; GroES-like_sf.
DR InterPro; IPR014031; Ketoacyl_synth_C.
DR InterPro; IPR014030; Ketoacyl_synth_N.
DR InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR InterPro; IPR013217; Methyltransf_12.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR InterPro; IPR032821; PKS_assoc.
DR InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR InterPro; IPR020807; PKS_dehydratase.
DR InterPro; IPR042104; PKS_dehydratase_sf.
DR InterPro; IPR020843; PKS_ER.
DR InterPro; IPR013968; PKS_KR.
DR InterPro; IPR020806; PKS_PP-bd.
DR InterPro; IPR009081; PP-bd_ACP.
DR InterPro; IPR006162; Ppantetheine_attach_site.
DR InterPro; IPR029063; SAM-dependent_MTases_sf.
DR InterPro; IPR016039; Thiolase-like.
DR Pfam; PF00698; Acyl_transf_1; 1.
DR Pfam; PF16197; KAsynt_C_assoc; 1.
DR Pfam; PF00109; ketoacyl-synt; 2.
DR Pfam; PF02801; Ketoacyl-synt_C; 1.
DR Pfam; PF08659; KR; 1.
DR Pfam; PF08242; Methyltransf_12; 1.
DR Pfam; PF00550; PP-binding; 1.
DR Pfam; PF14765; PS-DH; 1.
DR SMART; SM00827; PKS_AT; 1.
DR SMART; SM00826; PKS_DH; 1.
DR SMART; SM00829; PKS_ER; 1.
DR SMART; SM00825; PKS_KS; 1.
DR SMART; SM00823; PKS_PP; 1.
DR SUPFAM; SSF47336; SSF47336; 1.
DR SUPFAM; SSF50129; SSF50129; 1.
DR SUPFAM; SSF51735; SSF51735; 3.
DR SUPFAM; SSF52151; SSF52151; 1.
DR SUPFAM; SSF53335; SSF53335; 1.
DR SUPFAM; SSF53901; SSF53901; 1.
DR SUPFAM; SSF55048; SSF55048; 1.
DR PROSITE; PS50075; CARRIER; 1.
DR PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE 1: Evidence at protein level;
KW Acyltransferase; Methyltransferase; Multifunctional enzyme; NADP;
KW Oxidoreductase; Phosphopantetheine; Phosphoprotein; Reference proteome;
KW S-adenosyl-L-methionine; Transferase.
FT CHAIN 1..2527
FT /note="Asperfuranone polyketide synthase afoG"
FT /id="PRO_0000436374"
FT DOMAIN 2436..2513
FT /note="Carrier"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT REGION 15..414
FT /note="Ketosynthase (KS) domain"
FT /evidence="ECO:0000255"
FT REGION 534..847
FT /note="Malonyl-CoA:ACP transacylase (MAT)"
FT /evidence="ECO:0000255"
FT REGION 946..1255
FT /note="Dehydratase-like"
FT /evidence="ECO:0000255"
FT REGION 1526..1564
FT /note="Methyltransferase"
FT /evidence="ECO:0000255"
FT REGION 2405..2432
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 2407..2423
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 2473
FT /note="O-(pantetheine 4'-phosphoryl)serine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ SEQUENCE 2527 AA; 273245 MW; 7CE6C067D20FE51A CRC64;
MGSTSSEPTY DSEPIAIIGL SCKFAGSADS PEKLWEMLAE GRNAWSEIPE SRFNHKAVYH
PDSEKLGTTL DPQFRFQLES VYEALENEST AGLTIPSIAG TNTSVYAGVF THDYHEGLIR
DEDKLPRFLP IGTLSAMSSN RISHFFDLKG ASVTVDTGCS TALVALHQAV LGLRTREADM
SIVSGCNIML SPDMFKVFSS LGMLSPDGKS YAFDSRANGY GRGEGVATII VKRLADALRD
GDPVRGVIRE SYLNQDGKTE TITSPSQEAQ EALIKECYRR AGLSPSDTQY FEAHGTGTPT
GDPIEARSIA SVFGKNREQP LRIGSVKTNI GHTEAASGLA GLIKVVLAME KGFIPPSVNF
EKPNPKLKLD EWRLKVADTL EKWPAPAERP WRASVNNFGY GGTNSHVIVE GVPKRLYTPA
NGNETGQIKH ETESKVLLFS GRDEQACQRM VASTKEYLKK RREQDPPMTP EQVKTLMQNL
AWTLTQHRTR FSWVSAHAVK YSTSLDTVID ALESPPPASR PVRIPDSPFR IGMVFTGQGA
QWHAMGRELI AAYPVFKATL DEAEQYLRQL GAGWSLIEEL MKDAATTRVN DTGLSIPICV
AVQIALVRLL KAWGITASAV TSHSSGEIAA AYTVGALSLR QAMAAAYYRA AMAADKTLKS
AEGPQGAMVA VGVDKAAAQA YLDRVEKSAG RAVVACINSP SSITIAGDEA AVVAVEKLAT
EEGVFARRLR VETGYHSHHM EPIASPYREA LRAALAQEDA ESGTKDQTDV PGFADATKPG
SLDHTVFSSP VTGGRVTDAK VLSDPEHWVR SLLQPVRFVE AFTDMVLGST DSSNIDLILE
VGPHTALGGP IKEILALPDF SSRNVSLPYM GCLVRKEDAR DCMLTAALNL FSKGHSIDLL
RLSFSSGIPE LQVLTDLPSY PWNHSIRHWS ESRRNAAYRK RSQEPHELLG VLEPGTNPDA
ASWRHIIKLS EAPWLRDHVV QGNILYPGAG FVCLAIEAIK MQSAMSGTND VTGFRLRDVE
IHQALVIADS ADGVEVQTTL RSVGGKVIGA RGWKQFEIWS VSADSEWTEH ARGLITVDTE
TKASTLVAST LDESGYTRRI DPQDMFASLR AKGLNHGPMF QNTLRILQDG RAKEPQCVVD
IKIADVSSSK DSGRMSLLHP TTLDSIVLSS YAAVPSSDPS NDDSARVPRS IRSLWVSSMI
SSAPGHTFTC NVKMPHHDAQ SYEANVTVVD EAGARAESMV EMQGLVCQSL GRSAPAEDRE
PWTKELCANV EWAPDLSLSL GLPGSSDAID RRLNTLRDQN PDERSIEVQT VLRRVCVYFS
HDALSSLTEN DVANLAFHHV KFYKWMQDTV NLALARRWSA DSDTWIHDSP AVREKYISLA
GSQTVDGELI CQLGPLLLPV LRGERAPLEV MMEGRLLYKY YANAYRLEPA FEQLKSLLGA
ILHKNPRARV LEIGAGTGAA TRHALKTLGT DEDGGPRCES WHFTDISSGF FEAARAEFAT
WGGLLEFNKL DIEQDPEAQG FKLGSYDVVV ACQVLHATKS MHRTMTNVRS LMKPGGTLLL
METTQDQIDL QFIFGLLPGW WLSEEPERHA SPSLSIDMWD RVLKGAGFTG VEIDLRDVNV
DAESDLYGIS NIMSTAVGTA GSSPEKVDAA QVVIVTGNKT GFQDDWVRGL QAAIAQDSGS
DALPEIISLE SPSLGAEAFQ SRLVVFVGEL DRPVLASLDS TELEGIKTMA LACKGLLWVT
RGGAVECTDP DSALASGFVR VLRTEYLGRR FLTLDLDPAA HSPASDISVI VHLLSSRLQP
AVETAAPADS EFALRDGLLL VPRLYKDVVW NALLEPEVPD WASPEKPRAY GLNFRDVMVA
MGQLKERVMG LECAGVITRV GAEAAAQGFA VGDRVMALLL GPFSSRARVS WHGVASMPAG
MGFADAASIP MIFTTAYVAL VQAARLSQGQ TVLIHAAAGG VGQAAVILAK EYLGAEVFAT
VGSQEKRDLL IKEYGIPDDH IFNSRDSSFA PAALAATAGR GVDCLIEVLA PFGHFVEIGK
RDLEQNSLLE MATFTRAVSF TSLDMMTLLR QRGDEAHRVL SELARLAGQG IVKPVHPVSV
YPMRQVDKAF RLLQTGKHLG KLVLSTEPDE EVRVLPRPAT PKLRADASYL LVGGVGGLGR
SLASWMVEHG AKHLILLSRS AGKQDSSAFV NGLRDAGCRV AAISCDVADR ADLDRAIAAA
SELGFPHVRG VIQGAMVLQD SIIEQMSIAD WNAAIKPKVA GTRNLHDRFS QRNSLDFFVM
LSSLSAILGW ASQASYAAGG TYQDALARWR CSKGLPAVSL DMGVIKDVGY VAESRSVSDR
LRKVGQSLRL SEESILQTLA TAVLHPFGRP QLLLGLNSGP GSHWDPSSDS QMGRDARFAP
LRYRKPASTK SAQTSSSGDG EEPLSSKLKS ADSPDAAANY VGGAIATKLA DIFMVPVADI
DLTKPPSAYG VDSLVAVELR NMLVLQAACD VSIFSILQSV SLAALAGMVV EKSAHFEGSA
TGTVVVA